Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Inventory (2016 - 2025)

Standard Biotools (LAB) has disclosed Change in Inventory for 16 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 15.42% to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.3 million, a 67.88% decrease, with the full-year FY2024 number at $9.9 million, up 101.04% from a year prior.
  • Change in Inventory was $1.8 million for Q3 2025 at Standard Biotools, down from $4.7 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $6.4 million in Q2 2024 to a low of -$5.0 million in Q4 2024.
  • A 5-year average of $2.0 million and a median of $1.8 million in 2025 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: surged 6127.27% in 2022, then plummeted 403.8% in 2024.
  • Standard Biotools' Change in Inventory stood at -$2.7 million in 2021, then surged by 124.58% to $660000.0 in 2022, then skyrocketed by 150.91% to $1.7 million in 2023, then tumbled by 403.8% to -$5.0 million in 2024, then skyrocketed by 135.86% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Change in Inventory are $1.8 million (Q3 2025), $4.7 million (Q2 2025), and $3.8 million (Q1 2025).